Chemoinformaics analysis of Pelargonidin 3,5-diglucoside
| Molecular Weight | 630.983 | nRot | 7 |
| Heavy Atom Molecular Weight | 599.735 | nRig | 29 |
| Exact Molecular Weight | 630.135 | nRing | 5 |
| Solubility: LogS | -2.943 | nHRing | 3 |
| Solubility: LogP | -0.398 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 14 | APOL | 79.9706 |
| nHD | 10 | BPOL | 39.7794 |
| QED | 0.135 |
| Synth | 4.85 |
| Natural Product Likeliness | 1.488 |
| NR-PPAR-gamma | 0.053 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.981 |
| HIA | 0.854 |
| CACO-2 | -6.584 |
| MDCK | 0.0000307 |
| BBB | 0.167 |
| PPB | 0.789978 |
| VDSS | 0.595 |
| FU | 0.166244 |
| CYP1A2-inh | 0.151 |
| CYP1A2-sub | 0.015 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.113 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.149 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.004 |
| CL | 1.275 |
| T12 | 0.753 |
| hERG | 0.323 |
| Ames | 0.335 |
| ROA | 0.05 |
| SkinSen | 0.151 |
| Carcinogencity | 0.08 |
| EI | 0.023 |
| Respiratory | 0.01 |
| NR-Aromatase | 0.837 |
| Antiviral | Yes |
| Prediction | 0.622163 |